Ross B. FineSmith M.D. 31 Parkview Ave Basking Ridge, New Jersey 07920 Phone [login to view URL] CURRICULUM VITAE Pharmaceutical Industry Experience Medical and Neurology Consulting (January 2006-Present). Private consulting business to pharmaceutical marketing firms. Provide insight into marketing strategies designed to attract physicians. Assist in development of medical/pharmaceutical surveys. Novartis Pharmaceutical Company (December 2002- January 2005). Participated in educational seminars for company neurology pharmaceutical representatives. Shire Pharmaceuticals (August 1998-January 2005). Presenter on Speakers Bureau. Presentations to doctors groups and organizations. Discussed pharmacokinetics of Adderall XR and medication strategies to more successfully utilize the medication. Lilly Pharmaceuticals (May 2001- January 2005). Presenter on Speakers Bureau. Presentations to doctors groups and organizations. Discussed pharmacokinetics of Strattera and medication strategies to more successfully utilize the medication. Practice Experience Neurology Private Practice (August 1998- January 2006). Consultation practice. Evaluation and treatment of children and adults with neurological conditions. Hospital consultations in a 350 bed acute care hospital . Including Epilepsy Unit, Medical, Pediatric and Neonatal ICU evaluations. Atlantic Health System (July 1997-May 2000). Neurology Division Head for the Developmental Disability Center. Supervised neurological care for children and adults with developmental disorders. Coordinated care with physicians, nurses, psychologist and community representatives. Involved in lectures and teaching hospital staff, residents and community physicians about neurological issues in individuals with developmental disorders. Ross FineSmith, MD November 15, 2011 Page 2 UNIVERSITY APPOINTMENTS New York University Medical School (July 1996- May 2006): Clinical Instructor of Neurology. Involved in clinical research concerning neuroprotection and epilepsy. Involved in teaching pediatric and medical residents. Investigator Experience Principle Investigator: The Effect of Tocolytic Agents on the Incidence of Periventricular Leukomalacia and Cerebral Palsy in Preterm Infants. Randomized, multi-center study. Supported, in part, by the New Jersey Department of Office for Prevention. Principle Investigator: Tiagabine in the Treatment of Pediatric Patients with Partial Seizures. Morristown Memorial Hospital. Morristown, New Jersey. 1996-Present. Supported by Abbott Labs. Principle Investigator: Open Label Extension of Tiagabine in the Treatment of Pediatric Patients with Partial Seizures. Morristown Memorial Hospital. Morristown, New Jersey. 1996-Present. Supported by Abbott Labs. Principle Investigator: Open Label Study of Lamictal in Mentally Retarded Patients with Epilepsy. Morristown Memorial Hospital. Morristown, New Jersey. 1996-Present. Supported by Glaxo-Welcome. POSTDOCTORAL TRAINING New York University Medical Center (July 1993 - June 1996): Pediatric Neurology Fellowship. Morristown Memorial Hospital (July 1992 -June 1993): Pediatric Resident; PGY-2. Robert Wood Johnson University Hospital/ St. Peters Medical Center (July 1991 - June 1992): Pediatric Intern. Ross FineSmith, MD November 15, 2011 Page 3 EDUCATION University of Wisconsin-Madison (Behavioral Disabilities) 1980-1984 B.S. University of Pennsylvania (Premedical Curriculum) 1985-1986 University of North Carolina-Greensboro (Neurophysiology) 1987 The Chicago Medical School 1988- 1991 M.D. AWARDS and HONORS Physician of the Year Award. Association for Retarded Citizens. Parsippany, N.J. June, 1999 Guest Discussant. Hot Topics in Neonatology Conference. Washington, D.C.. December 1996. Magnesium and Brain Injury in Preterm Infants. BIBLIOGRAPHY ARTICLES McKee J.R., Sunder T.R., FineSmith R, Vuong A., Varner J.A., Hammer A.E. Barrett P.S. Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation. Epilepsy & Behavior 2000; 4: 386-394. Steven L Kugler, David E Mandelbaum, Ramesh Patel, Karla M Roopal, Xue Ming, Richard Koenigsberger, Ross Finesmith, Mary Zupanc. Efficacy and Tolerability of Tiagibine in Infantile Spasms. Epilepsia, abstract at the 54th Conference of the American Epilepsy Society 1999. Epilepsia 1999; 39:212. FineSmith R, Zampella E, Devinsky O. Vagal Nerve Stimulator: A New Approach to Medically Refractory Epilepsy. New Jersey Medicine 1999; June: 37-40. FineSmith R, Purnachander S. A Twin Study of Periventricular Leukomalacia in Preterm Infants. Annals of Neurology 1997; 41:321. Ross FineSmith, MD November 15, 2011 Page 4 FineSmith R, Roche K, Yellin P, Walsh K, Shen C, Zeglis M, Khan A, Fish I. The Effect of Magnesium on the Development of Cystic Periventricular Leukomalacia in the Preterm Infant. American Journal of Perinatology 1997; 14(5):63-67. Finesmith R., Roche K, Shah N, Sirikonda P, Yellin P, Walsh K, Shen C . Analysis of Variables Associated with Preterm Birth and their Predictive Value in Periventricular Leukomalacia. Annals of Neurology 1996; 40(2):322. FineSmith R, Yellin P, Khan A. The Effect of Magnesium on Ischemic Lesions in the Preterm Infant. Annals of Neurology 1995; 38(3):488. Kastner T., FineSmith R., and Walsh K. Long-Term Administration of Valproic Acid in the Treatment of Affective Symptoms in People with Mental Retardation. Journal of Psychopharmacology 1993; 13 (6): 448-451. BOOKS, CHAPTERS FineSmith R., Geller E., Devinsky O. Strange Tastes, Smells, Visions and Feelings: Non-Epileptic Events that Mimic Simple Partial Seizures, In: Clinical Imitators of Epilepsy, Eds. Kaplan P., Fisher R., 2005. FineSmith R. Epilepsy and Developmental Disabilities, In: Managing Epilepsy and Medical Conditions. Eds. Ettinger A., Devinsky O. Hartcourt Brace, 2002. FineSmith R. Community Based Anti-Epileptic Treatment in the Developmentally Disabled, In: Epilepsy and Developmentally Disabilities, Eds. Orrin Devinsky. Philadelphia, Pa. Butterworth-Heinhann, 2002. FineSmith R. Neurology section, in: Pediatric Dosing Handbook, Eds. L.G. Feld, and M. Cimino. Hudson, Ohio. Lexi-Comp Inc, 1998. McCandless, David W., and FineSmith, Ross B.: Chemically Induced Models of Epilepsy, In Animal Models of Neurological Disease, II, Metabolic Encephalopathies and the Epilepsy's, Eds. A. Boulton, G. Baker and R. Butterworth. Totawa, N.J. Humana Press, 1992.